Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease
Aspirin-exacerbated respiratory disease (AERD) is characterized by eosinophilic chronic rhinosinusitis with nasal polyps, asthma, and upper-/lower-respiratory tract reactions to nonsteroidal antiinflammatory drugs. Persistent, severe disease, anosmia, and alcohol sensitivity is typical. AERD is mediated by multiple pathways, including aberrant arachidonic acid metabolism leading to elevated leukotriene E4 and decreased prostaglandin E2. Mast cell mediators (prostaglandin D2) and unique properties of eosinophils and type 2 innate lymphoid cells, along with receptor-mediated signaling, also contribute to AERD pathogenesis. Pharmacologic therapies are a cornerstone of AERD treatment and include leukotriene modifiers, corticosteroids, biologics, and aspirin.
Source: Immunology and Allergy Clinics of North America - Category: Allergy & Immunology Authors: Kathleen Luskin, Hiral Thakrar, Andrew White Source Type: research
More News: Alcoholism | Allergy | Allergy & Immunology | Aspirin | Asthma | Corticosteroid Therapy | Polyps | Respiratory Medicine